REQUEST A DEMO
Total
USD $0.00
Search more companies

Ryvu Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Medical Laboratories
Full name: Ryvu Therapeutics S.A. Profile Updated: November 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

The activities of Ryvu Therapeutics S.A. should be considered in two aspects: research and development work, realized through their own research projects and conduct research services to external customers. The company's research activities consist of conducting a series of innovative projects, mainly in the area of ​​oncology, central nervous system diseases, including Alzheimer's disease and immunology.

Headquarters
ul. Leona Sternbacha 2
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Ryvu Therapeutics S.A. report to view the information.

Website: http://www.ryvu.com

Basic Information
Total Employees:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Outstanding Shares:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Registered Capital:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Financial Auditors:
Purchase the Ryvu Therapeutics S.A. report to view the information.
Incorporation Date:
October 06, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
17.37%
Purchase this report to view the information.
9.85%
Purchase this report to view the information.
9.22%
Purchase this report to view the information.
8.29%
Purchase this report to view the information.
7.86%
Subsidiaries
Biocentrum Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Ryvu Therapeutics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
48.16%
Total operating revenue
46.52%
Operating profit (EBIT)
-10.19%
EBITDA
-12.05%
Net Profit (Loss) for the Period
-18.68%
Total assets
-0.01%
Total equity
-31.53%
Operating Profit Margin (ROS)
38.26%
Net Profit Margin
25.82%
Return on Equity (ROE)
-18.18%
Debt to Equity Ratio
59.48%
Quick Ratio
-0.96%
Cash Ratio
0.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?